Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Illumina, Inc.    ILMN

ILLUMINA, INC.

(ILMN)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/09/2019 09/10/2019 09/11/2019 09/12/2019 09/13/2019 Date
266.84(c) 276.04(c) 289.66(c) 297.52(c) 300.91(c) Last
1 571 479 1 295 045 1 824 695 1 961 483 1 247 527 Volume
-1.17% +3.45% +4.93% +2.71% +1.14% Change
More quotes
Financials (USD)
Sales 2019 3 524 M
EBIT 2019 984 M
Net income 2019 946 M
Finance 2019 2 663 M
Yield 2019 -
Sales 2020 4 012 M
EBIT 2020 1 202 M
Net income 2020 991 M
Finance 2020 3 410 M
Yield 2020 -
P/E ratio 2019 46,9x
P/E ratio 2020 45,6x
EV / Sales2019 11,8x
EV / Sales2020 10,2x
Capitalization 44 234 M
More Financials
Company
Illumina specializes in the development, manufacturing and marketing of integrated systems for the analysis of genetic variation and biological function. The group's products are for genomic research centers, pharmaceutical companies, university institutions, clinical research organizations, and... 
More about the company
Surperformance© ratings of Illumina, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA, INC.
09/12ILLUMINA : Recommends Stockholders Reject Mini-Tender Offer by TRC Capital Corpo..
BU
07/31ILLUMINA : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
07/29ILLUMINA : 2Q Earnings Snapshot
AQ
07/29ILLUMINA INC : Results of Operations and Financial Condition, Financial Statemen..
AQ
07/29ILLUMINA : Reports Financial Results for Second Quarter of Fiscal Year 2019
BU
07/29GLOBAL MARKETS LIVE : Sprint, T-Mobile, Refinitiv, Pfizer…
07/17EXCLUSIVE : Woodford biotech stakes first off block in asset sale - source
RE
07/16ILLUMINA : Expands Genomics Accelerator to Cambridge, UK
BU
07/15Stocks to Watch: Circor International, Callon Petroleum, American Airlines, B..
DJ
07/15Stocks to Watch: Boeing, Gilead Sciences, Facebook, J&J and More
DJ
More news
Analyst Recommendations on ILLUMINA, INC.
More recommendations
Stock Trading Strategies
ILLUMINA - 2018
Underpinned by a support level
BUY
More Stock Trading Analysis
Sector news : Advanced Medical Equipment & Technology - NEC
09/11Dutch government to trim multinational tax deductions - NOS
RE
09/11GE Cuts Baker Hughes Stake -- WSJ
DJ
09/10Google, Amazon and Microsoft in Battle to Store Health Data in the Cloud
DJ
09/06NO PLACE LIKE HOME : Chinese firms stung by trade war build up domestic brands
RE
08/29SONY : in $760 million Olympus stake sale after investor Loeb's prodding
RE
More sector news : Advanced Medical Equipment & Technology - NEC
Chart ILLUMINA, INC.
Duration : Period :
Illumina, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ILLUMINA, INC.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 17
Average target price 323,06  $
Last Close Price 300,91  $
Spread / Highest target 19,6%
Spread / Average Target 7,36%
Spread / Lowest Target -12,3%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Ostadan Omead Executive Vice President-Products & Operations
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA, INC.0.33%44 234
THERMO FISHER SCIENTIFIC33.00%119 202
DANAHER CORPORATION37.45%101 163
INTUITIVE SURGICAL9.25%60 303
BOSTON SCIENTIFIC CORPORATION18.31%58 240
EDWARDS LIFESCIENCES CORPORATION43.30%45 649